Thirteenth annual pezcoller symposium: focusing analytical tools on complexity in cancer
- PMID: 12097304
Thirteenth annual pezcoller symposium: focusing analytical tools on complexity in cancer
Abstract
The physiopathology of cancer cells is the result of very complex signaling networks that represent in many cases distortions of the orderly networks regulating the physiology of normal cells. These networks are the consequence of the expression of, or the lack of expression of, genes, mutated or not, which represent the genomic profile of different types of or of individual cancers. The complex signaling pathways, the cross-talks among them, and the redundancies existing for several of them mediate not only the transmission of signals from the cell environment to the nucleus but also that from the nucleus to the other cellular components whose function is involved in cell proliferation, apoptosis, or differentiation. Modern approaches to cancer therapy and also prevention are aimed at identifying new molecular targets, pivotal to the life of the cancer cell, which would provide for specific sites of intervention. In the face of the enormous complexity of the phenomena on which the life of cancer cells is based, it is both difficult to identify unique specific target for intervention and important to develop analytical tools and approaches capable to identify them for further exploitation. This was the main subject of the Symposium. Consideration was given to: (a) tumor genotypic analysis through expression array evaluation and definition of cancer transcriptomes in studies aimed at identifying determinants of specific characteristics of cancer cells; (b) approaches based on the knowledge gained in this analysis that would lead to the visualization of new targets exploitable for antitumor action; and (c) multifactorial analysis of the complex interactions regulating cancer cells and methods to comprehend the complexity of molecular models and validate their functional relevance.
Similar articles
-
Twelfth annual Pezcoller symposium: signaling cross-talks in cancer cells.Cancer Res. 2000 Dec 15;60(24):7177-83. Cancer Res. 2000. PMID: 11156428
-
Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.Br J Radiol. 1993 Mar;66(783):181-96. doi: 10.1259/0007-1285-66-783-181. Br J Radiol. 1993. PMID: 7682469 Review.
-
Twenty-third annual Pezcoller Symposium: engineering influences in cancer research.Cancer Res. 2012 Feb 15;72(4):841-4. doi: 10.1158/0008-5472.CAN-11-3080. Epub 2012 Jan 11. Cancer Res. 2012. PMID: 22237623
-
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumors.Cancer Res. 2003 Jun 1;63(11):3005-8. Cancer Res. 2003. PMID: 12782611
-
Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.Head Neck. 2007 Mar;29(3):272-84. doi: 10.1002/hed.20529. Head Neck. 2007. PMID: 17230559 Review.
Cited by
-
Insights into TOR function and rapamycin response: chemical genomic profiling by using a high-density cell array method.Proc Natl Acad Sci U S A. 2005 May 17;102(20):7215-20. doi: 10.1073/pnas.0500297102. Epub 2005 May 9. Proc Natl Acad Sci U S A. 2005. PMID: 15883373 Free PMC article.
-
Cancer reduces transcriptome specialization.PLoS One. 2010 May 3;5(5):e10398. doi: 10.1371/journal.pone.0010398. PLoS One. 2010. PMID: 20454660 Free PMC article.